APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Disruptor Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Endocrine Disruptor Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 July 2026190 pages

Choose your research edition.

Industry ResearchEndocrine Disruptor Testing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Disruptor Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Endocrine Disruptor Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Disruptor Testing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Disruptor Testing Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Endocrine Disruptor Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Endocrine Disruptor Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endocrine Disruptor Testing include Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix and ToxStrategies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Endocrine Disruptor Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endocrine Disruptor Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endocrine Disruptor Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Endocrine Disruptor Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Endocrine Disruptor Testing Segment by Company

Charles River Laboratories

Labcorp

Eurofins Scientific

PerkinElmer

Intertek

Smithers

LAUS

Xenometrix

ToxStrategies

Fera Science

Compliance Services International

Staphyt

Creative Proteomics

Creative Bioarray

Endocrine Disruptor Testing Segment by Type

In Vitro (Cell-based) Testing

In Vivo (Animal) Testing

In Silico (Computational) Modeling

Others

Endocrine Disruptor Testing Segment by Application

Environmental Monitoring

Food Safety

Cosmetics and Personal Care Products

Public Health and Disease Prevention

Others

Endocrine Disruptor Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Disruptor Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Disruptor Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Disruptor Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Endocrine Disruptor Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endocrine Disruptor Testing industry.

Chapter 3: Detailed analysis of Endocrine Disruptor Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine Disruptor Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endocrine Disruptor Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of In Vitro (Cell-based) Testing Table 3. Key Players of In Vivo (Animal) Testing Table 4. Key Players of In Silico (Computational) Modeling Table 3. Key Players of Others Table 4. Global Endocrine Disruptor Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Environmental Monitoring Table 6. Key Players of Food Safety Table 7. Key Players of Cosmetics and Personal Care Products Table 8. Key Players of Public Health and Disease Prevention Table 9. Key Players of Others Table 10. Global Endocrine Disruptor Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Endocrine Disruptor Testing Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Endocrine Disruptor Testing Market Share by Region (2021-2026) Table 13. Global Endocrine Disruptor Testing Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Endocrine Disruptor Testing Market Share by Region (2027-2032) Table 15. Endocrine Disruptor Testing Industry Trends Table 16. Endocrine Disruptor Testing Industry Drivers Table 17. Endocrine Disruptor Testing Industry Opportunities and Challenges Table 18. Endocrine Disruptor Testing Industry Restraints Table 19. Global Endocrine Disruptor Testing Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Endocrine Disruptor Testing Revenue Market Share by Company (2021-2026) Table 21. Global Endocrine Disruptor Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Endocrine Disruptor Testing Key Company Head Office and Area Served Table 23. Global Endocrine Disruptor Testing Company, Product Type & Application Table 24. Global Endocrine Disruptor Testing Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Endocrine Disruptor Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Endocrine Disruptor Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Endocrine Disruptor Testing Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Endocrine Disruptor Testing Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Endocrine Disruptor Testing Revenue Market Share by Type (2021-2026) Table 31. Global Endocrine Disruptor Testing Revenue Market Share by Type (2027-2032) Table 32. Global Endocrine Disruptor Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Endocrine Disruptor Testing Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Endocrine Disruptor Testing Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Endocrine Disruptor Testing Revenue Market Share by Application (2021-2026) Table 36. Global Endocrine Disruptor Testing Revenue Market Share by Application (2027-2032) Table 37. Charles River Laboratories Company Information Table 38. Charles River Laboratories Business Overview Table 39. Charles River Laboratories Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Charles River Laboratories Endocrine Disruptor Testing Product Portfolio Table 41. Charles River Laboratories Recent Development Table 42. Labcorp Company Information Table 43. Labcorp Business Overview Table 44. Labcorp Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Labcorp Endocrine Disruptor Testing Product Portfolio Table 46. Labcorp Recent Development Table 47. Eurofins Scientific Company Information Table 48. Eurofins Scientific Business Overview Table 49. Eurofins Scientific Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Eurofins Scientific Endocrine Disruptor Testing Product Portfolio Table 51. Eurofins Scientific Recent Development Table 52. PerkinElmer Company Information Table 53. PerkinElmer Business Overview Table 54. PerkinElmer Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. PerkinElmer Endocrine Disruptor Testing Product Portfolio Table 56. PerkinElmer Recent Development Table 57. Intertek Company Information Table 58. Intertek Business Overview Table 59. Intertek Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Intertek Endocrine Disruptor Testing Product Portfolio Table 61. Intertek Recent Development Table 62. Smithers Company Information Table 63. Smithers Business Overview Table 64. Smithers Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Smithers Endocrine Disruptor Testing Product Portfolio Table 66. Smithers Recent Development Table 67. LAUS Company Information Table 68. LAUS Business Overview Table 69. LAUS Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. LAUS Endocrine Disruptor Testing Product Portfolio Table 71. LAUS Recent Development Table 72. Xenometrix Company Information Table 73. Xenometrix Business Overview Table 74. Xenometrix Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Xenometrix Endocrine Disruptor Testing Product Portfolio Table 76. Xenometrix Recent Development Table 77. ToxStrategies Company Information Table 78. ToxStrategies Business Overview Table 79. ToxStrategies Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. ToxStrategies Endocrine Disruptor Testing Product Portfolio Table 81. ToxStrategies Recent Development Table 82. Fera Science Company Information Table 83. Fera Science Business Overview Table 84. Fera Science Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Fera Science Endocrine Disruptor Testing Product Portfolio Table 86. Fera Science Recent Development Table 87. Compliance Services International Company Information Table 88. Compliance Services International Business Overview Table 89. Compliance Services International Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Compliance Services International Endocrine Disruptor Testing Product Portfolio Table 91. Compliance Services International Recent Development Table 92. Staphyt Company Information Table 93. Staphyt Business Overview Table 94. Staphyt Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Staphyt Endocrine Disruptor Testing Product Portfolio Table 96. Staphyt Recent Development Table 97. Creative Proteomics Company Information Table 98. Creative Proteomics Business Overview Table 99. Creative Proteomics Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Creative Proteomics Endocrine Disruptor Testing Product Portfolio Table 101. Creative Proteomics Recent Development Table 102. Creative Bioarray Company Information Table 103. Creative Bioarray Business Overview Table 104. Creative Bioarray Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Creative Bioarray Endocrine Disruptor Testing Product Portfolio Table 106. Creative Bioarray Recent Development Table 107. North America Endocrine Disruptor Testing Market Size by Type (2021-2026) & (US$ Million) Table 108. North America Endocrine Disruptor Testing Market Size by Type (2027-2032) & (US$ Million) Table 109. North America Endocrine Disruptor Testing Market Size by Application (2021-2026) & (US$ Million) Table 110. North America Endocrine Disruptor Testing Market Size by Application (2027-2032) & (US$ Million) Table 111. North America Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Endocrine Disruptor Testing Market Size by Country (2021-2026) Table 113. North America Endocrine Disruptor Testing Market Size by Country (2027-2032) Table 114. Europe Endocrine Disruptor Testing Market Size by Type (2021-2026) & (US$ Million) Table 115. Europe Endocrine Disruptor Testing Market Size by Type (2027-2032) & (US$ Million) Table 116. Europe Endocrine Disruptor Testing Market Size by Application (2021-2026) & (US$ Million) Table 117. Europe Endocrine Disruptor Testing Market Size by Application (2027-2032) & (US$ Million) Table 118. Europe Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Endocrine Disruptor Testing Market Size by Country (2021-2026) Table 120. Europe Endocrine Disruptor Testing Market Size by Country (2027-2032) Table 121. China Endocrine Disruptor Testing Market Size by Type (2021-2026) & (US$ Million) Table 122. China Endocrine Disruptor Testing Market Size by Type (2027-2032) & (US$ Million) Table 123. China Endocrine Disruptor Testing Market Size by Application (2021-2026) & (US$ Million) Table 124. China Endocrine Disruptor Testing Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Endocrine Disruptor Testing Market Size by Type (2021-2026) & (US$ Million) Table 126. Asia Endocrine Disruptor Testing Market Size by Type (2027-2032) & (US$ Million) Table 127. Asia Endocrine Disruptor Testing Market Size by Application (2021-2026) & (US$ Million) Table 128. Asia Endocrine Disruptor Testing Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Endocrine Disruptor Testing Market Size by Country (2021-2026) Table 131. Asia Endocrine Disruptor Testing Market Size by Country (2027-2032) Table 132. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Type (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Type (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Application (2021-2026) & (US$ Million) Table 135. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Application (2027-2032) & (US$ Million) Table 136. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2021-2026) Table 138. South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Endocrine Disruptor Testing Product Image Figure 2. Global Endocrine Disruptor Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Endocrine Disruptor Testing Market Share by Type: 2025 VS 2032 Figure 4. In Vitro (Cell-based) Testing Image Figure 5. In Vivo (Animal) Testing Image Figure 6. In Silico (Computational) Modeling Image Figure 7. Others Image Figure 8. Global Endocrine Disruptor Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Endocrine Disruptor Testing Market Share by Application: 2025 VS 2032 Figure 10. Environmental Monitoring Image Figure 11. Food Safety Image Figure 12. Cosmetics and Personal Care Products Image Figure 13. Public Health and Disease Prevention Image Figure 14. Others Image Figure 15. Global Endocrine Disruptor Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 17. Global Endocrine Disruptor Testing Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Endocrine Disruptor Testing Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Endocrine Disruptor Testing Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Endocrine Disruptor Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Endocrine Disruptor Testing Revenue Market Share by Type (2021-2032) Figure 24. Global Endocrine Disruptor Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Endocrine Disruptor Testing Revenue Market Share by Application (2021-2032) Figure 26. North America Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 27. North America Endocrine Disruptor Testing Market Share by Type (2021-2032) Figure 28. North America Endocrine Disruptor Testing Market Share by Application (2021-2032) Figure 29. North America Endocrine Disruptor Testing Market Share by Country (2021-2032) Figure 30. United States Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 31. Canada Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 33. Europe Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 34. Europe Endocrine Disruptor Testing Market Share by Type (2021-2032) Figure 35. Europe Endocrine Disruptor Testing Market Share by Application (2021-2032) Figure 36. Europe Endocrine Disruptor Testing Market Share by Country (2021-2032) Figure 37. Germany Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 38. France Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 40. Italy Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 41. Russia Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 43. China Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 44. China Endocrine Disruptor Testing Market Share by Type (2021-2032) Figure 45. China Endocrine Disruptor Testing Market Share by Application (2021-2032) Figure 46. Asia Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 47. Asia Endocrine Disruptor Testing Market Share by Type (2021-2032) Figure 48. Asia Endocrine Disruptor Testing Market Share by Application (2021-2032) Figure 49. Asia Endocrine Disruptor Testing Market Share by Country (2021-2032) Figure 50. Japan Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 54. India Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 55. Australia Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Endocrine Disruptor Testing Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Endocrine Disruptor Testing Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Endocrine Disruptor Testing Market Share by Country (2021-2032) Figure 60. Brazil Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 65. UAE Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 67. Chile Endocrine Disruptor Testing Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro (Cell-based) Testing
  • In Vivo (Animal) Testing
  • In Silico (Computational) Modeling
  • Others
Applications
  • Environmental Monitoring
  • Food Safety
  • Cosmetics and Personal Care Products
  • Public Health and Disease Prevention
  • Others
Companies covered
  • Charles River Laboratories
  • Labcorp
  • Eurofins Scientific
  • PerkinElmer
  • Intertek
  • Smithers
  • LAUS
  • Xenometrix
  • ToxStrategies
  • Fera Science
  • Compliance Services International
  • Staphyt
  • Creative Proteomics
  • Creative Bioarray

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Endocrine Disruptor Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro (Cell-based) Testing
  5. 1.2.3 In Vivo (Animal) Testing
  6. 1.2.4 In Silico (Computational) Modeling
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Endocrine Disruptor Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Environmental Monitoring
  11. 1.3.3 Food Safety
  12. 1.3.4 Cosmetics and Personal Care Products
  13. 1.3.5 Public Health and Disease Prevention
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Endocrine Disruptor Testing Growth Trends by Region
  17. 1.5.1 Global Endocrine Disruptor Testing Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Endocrine Disruptor Testing Market Size by Region (2021-2026)
  19. 1.5.3 Endocrine Disruptor Testing Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Endocrine Disruptor Testing Market Dynamics
  1. 2.1 Endocrine Disruptor Testing Industry Trends
  2. 2.2 Endocrine Disruptor Testing Industry Drivers
  3. 2.3 Endocrine Disruptor Testing Industry Opportunities and Challenges
  4. 2.4 Endocrine Disruptor Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Endocrine Disruptor Testing Revenue by Company (2021-2026)
  2. 3.2 Global Endocrine Disruptor Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Endocrine Disruptor Testing Key Company Head office and Area Served
  4. 3.4 Global Endocrine Disruptor Testing Company, Product Type & Application
  5. 3.5 Global Endocrine Disruptor Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Endocrine Disruptor Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Endocrine Disruptor Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Endocrine Disruptor Testing Tier 1, Tier 2, and Tier 3
4 Endocrine Disruptor Testing Market by Type
  1. 4.1 Global Endocrine Disruptor Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Endocrine Disruptor Testing Market Size by Type (2021-2032)
  3. 4.3 Global Endocrine Disruptor Testing Market Size Share by Type (2021-2032)
5 Endocrine Disruptor Testing Market by Application
  1. 5.1 Global Endocrine Disruptor Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Endocrine Disruptor Testing Market Size by Application (2021-2032)
  3. 5.3 Global Endocrine Disruptor Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Charles River Laboratories
  2. 6.1.1 Charles River Laboratories Company Information
  3. 6.1.2 Charles River Laboratories Business Overview
  4. 6.1.3 Charles River Laboratories Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Charles River Laboratories Endocrine Disruptor Testing Product Portfolio
  6. 6.1.5 Charles River Laboratories Recent Developments
  7. 6.2 Labcorp
  8. 6.2.1 Labcorp Company Information
  9. 6.2.2 Labcorp Business Overview
  10. 6.2.3 Labcorp Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Labcorp Endocrine Disruptor Testing Product Portfolio
  12. 6.2.5 Labcorp Recent Developments
  13. 6.3 Eurofins Scientific
  14. 6.3.1 Eurofins Scientific Company Information
  15. 6.3.2 Eurofins Scientific Business Overview
  16. 6.3.3 Eurofins Scientific Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eurofins Scientific Endocrine Disruptor Testing Product Portfolio
  18. 6.3.5 Eurofins Scientific Recent Developments
  19. 6.4 PerkinElmer
  20. 6.4.1 PerkinElmer Company Information
  21. 6.4.2 PerkinElmer Business Overview
  22. 6.4.3 PerkinElmer Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 PerkinElmer Endocrine Disruptor Testing Product Portfolio
  24. 6.4.5 PerkinElmer Recent Developments
  25. 6.5 Intertek
  26. 6.5.1 Intertek Company Information
  27. 6.5.2 Intertek Business Overview
  28. 6.5.3 Intertek Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Intertek Endocrine Disruptor Testing Product Portfolio
  30. 6.5.5 Intertek Recent Developments
  31. 6.6 Smithers
  32. 6.6.1 Smithers Company Information
  33. 6.6.2 Smithers Business Overview
  34. 6.6.3 Smithers Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Smithers Endocrine Disruptor Testing Product Portfolio
  36. 6.6.5 Smithers Recent Developments
  37. 6.7 LAUS
  38. 6.7.1 LAUS Company Information
  39. 6.7.2 LAUS Business Overview
  40. 6.7.3 LAUS Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 LAUS Endocrine Disruptor Testing Product Portfolio
  42. 6.7.5 LAUS Recent Developments
  43. 6.8 Xenometrix
  44. 6.8.1 Xenometrix Company Information
  45. 6.8.2 Xenometrix Business Overview
  46. 6.8.3 Xenometrix Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Xenometrix Endocrine Disruptor Testing Product Portfolio
  48. 6.8.5 Xenometrix Recent Developments
  49. 6.9 ToxStrategies
  50. 6.9.1 ToxStrategies Company Information
  51. 6.9.2 ToxStrategies Business Overview
  52. 6.9.3 ToxStrategies Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ToxStrategies Endocrine Disruptor Testing Product Portfolio
  54. 6.9.5 ToxStrategies Recent Developments
  55. 6.10 Fera Science
  56. 6.10.1 Fera Science Company Information
  57. 6.10.2 Fera Science Business Overview
  58. 6.10.3 Fera Science Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Fera Science Endocrine Disruptor Testing Product Portfolio
  60. 6.10.5 Fera Science Recent Developments
  61. 6.11 Compliance Services International
  62. 6.11.1 Compliance Services International Company Information
  63. 6.11.2 Compliance Services International Business Overview
  64. 6.11.3 Compliance Services International Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Compliance Services International Endocrine Disruptor Testing Product Portfolio
  66. 6.11.5 Compliance Services International Recent Developments
  67. 6.12 Staphyt
  68. 6.12.1 Staphyt Company Information
  69. 6.12.2 Staphyt Business Overview
  70. 6.12.3 Staphyt Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Staphyt Endocrine Disruptor Testing Product Portfolio
  72. 6.12.5 Staphyt Recent Developments
  73. 6.13 Creative Proteomics
  74. 6.13.1 Creative Proteomics Company Information
  75. 6.13.2 Creative Proteomics Business Overview
  76. 6.13.3 Creative Proteomics Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Creative Proteomics Endocrine Disruptor Testing Product Portfolio
  78. 6.13.5 Creative Proteomics Recent Developments
  79. 6.14 Creative Bioarray
  80. 6.14.1 Creative Bioarray Company Information
  81. 6.14.2 Creative Bioarray Business Overview
  82. 6.14.3 Creative Bioarray Endocrine Disruptor Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Creative Bioarray Endocrine Disruptor Testing Product Portfolio
  84. 6.14.5 Creative Bioarray Recent Developments
7 North America
  1. 7.1 North America Endocrine Disruptor Testing Market Size (2021-2032)
  2. 7.2 North America Endocrine Disruptor Testing Market Size by Type
  3. 7.2.1 North America Endocrine Disruptor Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Endocrine Disruptor Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Endocrine Disruptor Testing Market Share by Type (2021-2032)
  6. 7.3 North America Endocrine Disruptor Testing Market Size by Application
  7. 7.3.1 North America Endocrine Disruptor Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Endocrine Disruptor Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Endocrine Disruptor Testing Market Share by Application (2021-2032)
  10. 7.4 North America Endocrine Disruptor Testing Market Size by Country
  11. 7.4.1 North America Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Endocrine Disruptor Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Endocrine Disruptor Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Endocrine Disruptor Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Endocrine Disruptor Testing Market Size (2021-2032)
  2. 8.2 Europe Endocrine Disruptor Testing Market Size by Type
  3. 8.2.1 Europe Endocrine Disruptor Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Endocrine Disruptor Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Endocrine Disruptor Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Endocrine Disruptor Testing Market Size by Application
  7. 8.3.1 Europe Endocrine Disruptor Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Endocrine Disruptor Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Endocrine Disruptor Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Endocrine Disruptor Testing Market Size by Country
  11. 8.4.1 Europe Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Endocrine Disruptor Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Endocrine Disruptor Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Endocrine Disruptor Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Endocrine Disruptor Testing Market Size (2021-2032)
  2. 9.2 China Endocrine Disruptor Testing Market Size by Type
  3. 9.2.1 China Endocrine Disruptor Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Endocrine Disruptor Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Endocrine Disruptor Testing Market Share by Type (2021-2032)
  6. 9.3 China Endocrine Disruptor Testing Market Size by Application
  7. 9.3.1 China Endocrine Disruptor Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Endocrine Disruptor Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Endocrine Disruptor Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Endocrine Disruptor Testing Market Size (2021-2032)
  2. 10.2 Asia Endocrine Disruptor Testing Market Size by Type
  3. 10.2.1 Asia Endocrine Disruptor Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Endocrine Disruptor Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Endocrine Disruptor Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Endocrine Disruptor Testing Market Size by Application
  7. 10.3.1 Asia Endocrine Disruptor Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Endocrine Disruptor Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Endocrine Disruptor Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Endocrine Disruptor Testing Market Size by Country
  11. 10.4.1 Asia Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Endocrine Disruptor Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Endocrine Disruptor Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Endocrine Disruptor Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Endocrine Disruptor Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Endocrine Disruptor Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Endocrine Disruptor Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Endocrine Disruptor Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst